US 11696922
Nanoparticle to target cancer
granted A61KA61K31/7088A61K31/713
Quick answer
US patent 11696922 (Nanoparticle to target cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jul 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/7088, A61K31/713, A61K47/10, A61K47/183